Action of interferon α and β on four human melanoma cell lines in vitro

Anticancer Research

Volumn 16, Issue 2, 1996, Pages 791-798

  Köpf, J István ^a,b   Hanson, C ^a   Delle, U ^a   Weimarck, A ^a   Stierner, U ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

21q dosage; Chromosome 9p; FISH; Interferon sensitivity; Melanoma cell lines; PCR

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON RECEPTOR;

ARTICLE; CHROMOSOME 21Q; CHROMOSOME 9; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; HUMAN; HUMAN CELL; MELANOMA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR CELL LINE;

CHROMOSOMES, HUMAN, PAIR 9; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERFERON-ALPHA; INTERFERON-BETA; MELANOMA; POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0029994487     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Diaz MO, Pomykala HM, Bohlander SK, Maltepe E, Malik K, Brownstein B and Olopade OI: Structure of the human type-I Interferon gene cluster determined from a YAC clone contig. Genomics 22: 540-552, 1994.
2. Trent JM, Olson S and Lawn RM: Chromosomal localization of human leukocyte, fibroblast, and immune interferon genes by means of in situ hybridization. Proc Natl Acad Sci USA 79: 7809-7813, 1982.
3. Diaz MO, Le Beau MM, Pitha P and Rowley JD: Interferon and c-ets-1 genes in the translocation (9;11) (p22;q23) in human acute monocytic leukemia. Science 231: 265-267, 1986.
4. 1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci USA 85: 5259-5263, 1988.
5. Olopade OI, Bohlander SK, Pomykala H, Maltepe E, Van Melle E, Le Beau MM and Diaz MO: Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia. Genomics 14: 437-443, 1992.
6. Diaz MO, Rubin CM, Harden A, Ziemin S, Larson RA, Le Beau MM and Rowley JD: Deletions of interferon genes in acute lymphoblastic leukemia. N Engl J Med 322(2): 77-82, 1990.
7. Einhorn S, Grandér D, Björk O, Bröndum-Nielsen K and Söderhäll S: Deletion of α-, β- and ω interferon genes in malignant cells from children with acute lymphocytic leukemia. Cancer Res 50: 7781-7785, 1990.
8. Bigner SH, Mark J, Bullard DE, Mahaley MS Jr and Bigner DD: Chromosomal evolution in malignant human gliomas starts with specific and usually numerical deviations. Cancer Genet Cytogenet 22: 121-135, 1986.
9. Bigner SH, Mark J, Burger PC, Mahaley MS Jr, Bullard DE, Muhlbaier LH and Bigner DD: Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 88: 405-411, 1988.
10. Shen V, Walter B, Haddad M, Wagner C, Bernstein R, Katz J, Young R and Smith M: Deletions or loss of chromosomes 9 and 10 in astrocytomas. Cytogenet Cell Genet 51: 1077, 1989.
11. Miyakoshi J, Dobler KD, Allalunis-Turner J, McKean JDS, Petruk K, Allen PBR, Aronyk KN, Weir B, Huyser- Wierenga D, Fulton D, Urtasun RC and Day III RS: Absence of IFNA and IFNB Genes from Human Malignant Glioma Cell Lines and Lack of Correlation with Cellular Sensitivity to Interferonsl. Cancer Res 50: 278-283, 1990.
12. James CD, He J, Carlbom E, Nordenskjold M, Cavenee WK and Collins VP: Chromosome 9 deletion mapping reveals interferon α and interferon β-1 gene deletions in human glial tumors. Cancer Res 51: 1684-1688, 1991.
13. Lukeis R, Irving L, Garson M and Hasthorpe S: Cytogenetics of non-small cell lung cancer: Analysis of consistent non-random abnormalities. Genes Chromosom Cancer 2: 116-124, 1990.
14. Dracopoli NC, Alhadeff B, Houghton AN and Old LJ: Loss of heterozygosity at autosomal and X-linked loci during tumor progression in a patient with melanoma. Cancer Res 47: 3995-4000, 1987.
15. Cowan JM, Halaban R and Francke U: Cytogenetic analysis of melanocytes from premalignant nevi and melanomas. J Natl Cancer Inst 80(14): 1159-1164, 1988.
16. Pedersen MI and Wang N: Chromosomal evolution in the progression and metastasis of human malignant melanoma. Cancer Genet Cytogenet 41: 185-201, 1989.
17. Fountain JW, Bale SJ, Housman DE and Dracopoli NC: Genetics of melanoma. Cancer Surv 9: 645-671, 1990.
18. Fountain JW, Karayiorgou M, Graw SL, Buckler AJ, Taruscio D, Ward DC, Ernstoff MS, Kirkwood JM, Andersen LB, Collins FS, Dracopoli NC, and Housman DE: Chromosome 9p involvement in melanoma. Am J Hum Genet Suppl 49: 45, 1991.
19. Kowalczyk J and Sandherg AA: A Possible Subgroup of ALL with 9p-. Cancer Genet Cytogenet 9: 383-385, 1983.
20. Chilcote RR, Brown E and Rowley JD: Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9. New Engl J Med 313(5): 286-291, 1985.
21. Pollak C and Hagemeijer A: Abnormalities of the short arm of chromosome 9 with partial loss of material in hematological disorders. Leukemia 1(7): 541-548, 1987.
22. Carroll AJ, Castleberry RP and Crist WM: Lack of association between abnormalities of the chromosome 9 short arm and either ́Lymphomatouś features of T cell phenotype in childhood acute lymphocytic leukemia. Blood 69(3): 735-738, 1987.
23. Murphy SB, Raimondi SC, Rivera GK, Crone M, Dodge RK, Behm FG, Pui C-H and Williams DL: Nonrandom abnormalities of chromosome 9p in childhood acute lymphoblastic leukemia: Association with high-risk clinical features. Blood 74(1): 409-415, 1989.
24. Colamonici OR, Domanski P, Platanias LC and Diaz MO: Correlation between interferon (IFN) α resistance and deletion of the IFN α/β genes in acute leukemia cell lines suggests selection against the IFN system. Blood 80: 744-749, 1992.
25. Heyman M, Grandér D, Bröndum-Nielsen K, Cederblad B, Liu Y, Xu B and Einhorn S: Interferon system defects in malignant T-cells. Leukemia 8: 425-434, 1994.
26. Henn W, Werner M, Fischer H and Zang KD: Evolution of a 9p-marker in human glioblastoma cell lines. Cytogenet Cell Genet Abstract 46: 628, 1987.
27. Olopade OI, Jenkins RB, Ransom DT, Malik K, Pomykala H, Nobori T, Cowan JM, Rowley JD and Diaz MO: Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res 52: 2523-2529, 1992.
28. Cheng JO, Jhanwar SC, Lu YY and Testa JR: Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas. Cancer Res 53: 4761-4763, 1993.
29. Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestana A and Rey JA: Molecular analysis of genomic abnormalities in human gliomas. Cancer Genet Cytogenet 73: 122-129, 1994.
30. Ozisik YY, Meloni AM, Altungoz O, Peier A, Karakousis C, Leong SPL and Sandberg AA: Cytogenetic findings in 21 malignant melanomas. Cancer Genet Cytogenet 77: 69-73, 1994.
31. Petty EM, Gibson LH, Fountain JW, Bolognia JL, Yang-Feng TL, Housman DE and Bale AE: A chromosome 9p21 germline deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor suppressor gene(s). Cytogenet Cell Genet 64: 118, 1993.
32. Epstein CJ, McManus NH and Epstein LB: Direct evidence that the gene product of the human chromosome 21 locus, IFRC, is the interferon-α receptor. Biochem Biophys Res Commun 107: 1060-1066, 1982.
33. Raziuddin A, Sarkar FH, Dutkowski R, Shulman L, Ruddle FH and Gupta SL: Receptors for human α and β interferon but not for γ-interferon are specified by human chromosome 21. Proc Natl Acad Sci USA 81: 5504-5508, 1984.
34. Langer JA, Rashidbaigi A, Lai LW, Patterson D, and Jones C: Sublocalization on chromosome 21 of human interferon alpha receptor gene and the gene for an interferon gamma response protein. Somat Cell Molec Genet 16: 231-240, 1990.
35. Lutfalla G, Roeckel N, Mogensen KE, Mattel MG, and Uzé G: Assignment of the human interferon alpha receptor gene to chromosome 21q22.1 by in situ hybridization. J Interferon Res 10: 515-517, 1990.
36. Lutfalla G, Gardiner K, Proudhon D, Vielh E and Uzé G: The structure of the human interferon α/β receptor gene. J Biol Chem 267: 2802-2809, 1992.
37. Branca AA and Baglioni C: Evidence that types I and II interferons have different receptors. Nature 294: 768-770, 1981.
38. 125I-labelled human interferons alpha, beta and gamma: Comparative receptor-binding data. J Gen Virol 66: 1149-1152, 1985.
39. Uzé G, Lutfalla G, Eid P, Maury C, Bandu M-T, Gresser I and Mogensen K: Murine tumor cells expressing the gene for the human interferon aβ receptor elicit antibodies in syngeneic mice to the active form of the receptor. Eur J Immunol 21: 447-451, 1991.
40. Myoshi H, Shimizhu K, Kozu T, Maseki N, Kaneko Y, Ohki M: t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 88: 10431-10434, 1991.
41. Berger R, Hillion J, Janvier D, Chen Z and Bussel A: t(8;21) prior to acute leukemia. Cancer Genet Cytogenet 70: 125-126, 1993.
42. Nobbs MC, Chan-Lam D, Howell RT, Kithen C and Copplestone JA: Acute non-lymphocytic leukemia with t(16:21). Cancer Genet Cytogenet 70: 144-145, 1993.
43. de Greef GE, Hagemeijer A, Morgan R, Wijsman J, Hoefsloot LH, Sandberg AA and Sacchi N: Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8:21) acute myeloid leukemia. Leukemia 9: 282-287, 1995.
44. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, BrayWard P, Morgan E, Raimondi SC, Rowley JD and Gilliland DG: Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 92: 4917-4921, 1995.
45. Kahaki S, Hayata I, and Sandberg AA: Chromosomes and causation of human cancer and leukemia. X. Banding patterns in cancerous effusions. Cancer 36: 1729-1738, 1975.
46. Kovacs G: Serial cytogenetic analysis in a patient with pseudodiploid bladder cancer. J Cancer Res Clin Oncol 110: 249-251, 1985.
47. Jenkyn DJ and McCartney AJ: A Chromosome Study of Three Ovarian Tumors. Cancer Genet Cytogenet 26: 327-337, 1987.
48. Berger CS, Sandberg AA, Todd IAD, Pennington RD, Haddad FS, Hecht BK, and Hecht F: Chromosomes in kidney, ureter, and bladder cancer. Cancer Genet Cytogenet 23: 1-24, 1986c.
49. Sato S, Nakamura Y, and Tsuchiya E: Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 54: 5652-5655, 1994.
50. Aoki T, Mori T, Du X, Nishira T, Matsubara T, and Nakamura Y: Allelotype study of esophageal carcinoma. Genes Chromosom Cancer 10: 177-182, 1994.
51. Cliby W, Ritland S, Hartmann L, Dodson M, Hailing KC, Keeney G, Podratz KC and Jenkins, RB: Human epithelial ovarian cancer allelotype. Cancer Res 53: 2393-2398, 1993.
52. Trent JM, Thompson FH and Meyskens FL Jr.: Identification of a recurring translocation site involving chromosome 6 in human malignant melanoma. Cancer Res 49: 420-423, 1989.
53. Weil J, Tucker G, Epstein LB and Epstein CJ: Interferon induction of (2′-5′) oligoisoadenylale synthetase in diploid and trisomy 21 human fibroblasts: Relation to dosage of the interferon receptor gene (IFRC). Hum Genet 65: 108-111, 1983.
54. Köpf I, Stierner U, Islam Q, Delle U, Kindblom L-G and Martinsson T: Characterization of four melanoma cell lines with electron microscopy, immunocytochemistry, cytogenetics, flow cytometry, and southern analysis. Cancer Genet Cytogenet 62(2): 111-123, 1992.
55. Seabright M: A rapid banding technique for human chromosomes. Lancet II: 971-972, 1971.
56. Sumner AT: A simple technique for demonstrating centromeric heterochromatin. Exp Cell Res 75: 304-306, 1972.
57. Jakobsson A-H, Hanson C, Wikland M and Hamberger L: Fluorescent in situ hybridization analysis of chromosomally normal gametes and abnormal arrested embryos. J Assist Reprod Genet 12: 422-427, 1995.
58. Brandt ER, Devenish RJ, Cheetham BF and Linnane AW: Detection of human Interferon-α-encoding gene expression. Gene 127: 261-266, 1993.
59. Avramopoulus D, Chakravarti A and Antonarakis SE: DNA polymorphisms in the 3'untranslated region of genes on human chromosome 21. Genomics 15: 98-102, 1993.
60. Armitage P and Berry G: Statistical methods in medical research. 2nd ed. Oxford: Blackwell, 1987.
61. Einhorn S, Grandér D, Björk O and Söderhäll S: Loss of α- and, β-interferon genes in malignant cells from children with acute lymphocytic leukemia. J Interferon Res 9: 105, 1989.
62. Cook AW, Carter WA, Nidzgorski F and Akhtar L: Human brain tumor-derived cell lines: growth rate reduced by human fibroblast interferon. Science 219: 881-883, 1983.
63. Creasey AA, Epstein DA, Marsh YV, Khan Z and Merigan TC: Growth regulation of melanoma cells by interferon (2′-5′) oligoadenylate synthetase. Mol Cell Biol 3: 780-786, 1983.
64. Creasey AA, Bartholomew JC and Merigan TC: Role of G0-G1 arrest in the inhibition of tumor cell growth by interferon. Proc Natl Acad Sci USA 77: 1471-1475, 1980.
65. Gomi K, Morimoto M and Nakamizo N: Growth-inhibitory activity of recombinant human interferon-β against cultured human cells. Gann 74: 737-742, 1983.
66. 6-methylguanine and hypersensitive to killing by human α and β interferons. Carcinogenesis 6: 883-886, 1985.
67. Gresser I, Brouty-Boyé D, Thomas M-T and Macieira-Coelho A: Interferon and cell division. II. Influence of various experimental condition on the inhibition of L1210 cell multiplication in vitro by interferon preparations. J Natl Cancer Inst 45: 1145-1153, 1970.
68. Paucker K, Cantell K and Henle W: Quantitative studies on viral interference in suspended L cells. III. Effect of interfering viruses and interferon on the growth rate of cells. Virology 17: 324-334, 1962.
69. Einhorn S and Strander H: Interferon therapy for neoplastic diseases in man. In vitro and in vivo studies. Human interferon. Production and clinical use. A symposium workshop, Vol. 19-20 May. Lake Placid, New York, USA: W. Alton Jones Cell Science Center, 1977.
70. Östlund L, Einhorn S, Robért K-H, Juliusson G and Biberfeld P: Chronic B-lymphocytic leukemia cells proliferate and differentiate following exposure to interferon in vitro. Blood 67: 152, 1986.
71. Brinckerhoff CE and Guyre PM: Increased proliferation of human synovial fibroblasts treated with recombinant immune interferon. J Immunol 134: 3142, 1985.
72. Ishihara K, Hayasaka K and Yamazaki N: Current status of melanoma treatment with Interferon, Cytokines and Other Biologic Response Modifiers in Japan. J Invest Dermatol 92(Suppl 5): 326S-328S, 1989.
73. Weil J, Epstein LB, and Epstein CJ: Synthesis of interferon-induced polypeptides in normal and chromosome 21-aneuploid human fibroblasts: relationship to relative sensitivities in antiviral assays. J Interferon Res 1: 111-124, 1980.